🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be a phase I, first time in human (FiH), randomized, single...
Status
Completed
Location
Research Site
Start Date
2016-12-16
Trial ID
NCT02935712
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Recruiting
Location
University of Alabama At Birmingham Hospital
Start Date
2025-12-11
Trial ID
NCT07222267
Treatments Being Tested
The study described in this protocol is a Phase 1, single center clinical t...
Status
Withdrawn
Location
The University of Texas MD Anderson Cancer Centre
Start Date
2026-02
Trial ID
NCT05634954
Treatments Being Tested
The purpose of this study is to assess the safety, pharmacokinetics and pha...
Status
Unknown
Location
MRA Clinical Research
Start Date
2009-12
Trial ID
NCT01038947
Treatments Being Tested
Introduction: The risk of systemic toxicity when using bupivacaine is a per...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT02755532
Treatments Being Tested
Regional anaesthesia has become the cornerstone of multimodal analgesia. Wi...
Status
Completed
Location
Cork University Hospital
Start Date
2011-08
Trial ID
NCT01756443
Treatments Being Tested
This is a randomized, double blind, positive controlled study to evaluate t...
Status
Unknown
Location
Linli County Center for Disease Control and Prevention
Start Date
2022-05-10
Trial ID
NCT05374954
Treatments Being Tested
This is a Phase 1, open label, non-randomised, dose-escalation single agent...
Status
Unknown
Location
Jiangsu Cancer Hospital
Start Date
2021-06-02
Trial ID
NCT04954456
Treatments Being Tested
This study is to determine the minimum effective dose for intrathecal chlor...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-16
Trial ID
NCT03805503
Treatments Being Tested
A study of adebelimab in combination with chemotherapy in the first-line tr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02-01
Trial ID
NCT06614621
Treatments Being Tested